The Selective Expression of Ret Finger Protein in Endometrial Cancer: Can RFP be a Marker of Serous Carcinomas? | Zendy

Gaye Güler Tezel | Zendy; Zehra Ordulu | Zendy; Çiğdem Himmetoğlu | Zendy; Alp Usubütün | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Selective Expression of Ret Finger Protein in Endometrial Cancer: Can RFP be a Marker of Serous Carcinomas?

Author(s) -

Gaye Güler Tezel,

Zehra Ordulu,

Çiğdem Himmetoğlu,

Alp Usubütün

Publication year - 2012

Publication title -

turkish journal of pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.305

H-Index - 14

eISSN - 1309-5730

pISSN - 1018-5615

DOI - 10.5146/tjpath.2012.01127

Subject(s) - serous fluid , endometrial cancer , medicine , endometrium , serous carcinoma , carcinoma , pathology , endometrial hyperplasia , atypical hyperplasia , malignancy , carcinogenesis , ovarian cancer , cancer , cancer research , oncology

Endometrial cancer is a common malignancy of the gynecological system and has been classified into two major groups, Types I and II. Type I tumors are estrogen-related, low-grade endometrioid tumors, whereas type II tumors are aggressive, high-grade non-endometrioid tumors. Ret finger protein is a nuclear transcription factor with a tripartite motif that is highly expressed in different tumor cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research